Autoimmune Diseases

Evidence-based recommendations focus on immunomodulators, biologics, and small molecules for the management of ulcerative colitis.

Pharmacists can play an integral role in managing patients with psoriasis through medication therapies and lifestyle modifications. 

Osteoarthritis is the most common type of arthritis, affecting nearly 54 million people.

Biosimilar to Remicade

Delayed-release oral capsules for various forms of the disease.

Fourth indication expansion for the 2009 drug.

How to help manage two of the most common autoimmune diseases.

A new law gives pharmacists increased authority.

Currently only approved for men and transgender women; future trials expected.

Psoriasis, MS, Lupus, and RA.

Monoclonal antibody for autoimmune and neurodegenerative disorders.

Monoclonal antibody shows potential for lupus nephritis treatment.

Current phase 3 studies investigative novel, preventative approaches.

Black box warns of increased risk of blood clots and death.

TNF blocker biosimilar to Humira (adalimumab, Abbvie).

Pharmacists need to remain vigilant about HIV with testing, prevention, treatment, and education of HIV.

Complement inhibitor is the first treatment for the rare autoimmune disorder.

Walgreens and several organizations will educate about HIV testing and antiretroviral medications to prevent HIV transmission on National HIV Testing Day on June 27.

Two studies outline the risks of shingles for patients with IBD.

Ruzurgi approval for rare autoimmune disorder may be an olive branch.

The next-generation oral drug is the first to be approved specifically for secondary progressive multiple sclerosis in more than 15 years.

1.1 million Americans live with HIV-here’s how you can help.